| Kim, Tae Jin, Associate Professor
Laboratory of Immunopathology
Tel: +82-31-299-6161
Fax: +82-31-299-6179
e-mail: tjkim@med.skku.ac.kr
|
Background:
| 1982 Mar 1988 Feb: |
M.D. from College of Medicine, Seoul National
University |
| 1988 Mar 1989 Feb: |
Intern, Seoul National University Hospital |
| 1989 Mar - 1991 Feb: |
M.Sc from Department of Pathology, Seoul National
University |
| 1989 Mar 1992 Feb: |
Resident in Department of Pathology of Seoul National
University Hospital |
| 1991 Mar 1994 Feb: |
Ph.D. from Department of Pathology, Seoul National
University |
| 1993 Apr 1997 Mar: |
Research fellow in Massachusetts General Hospital
Cancer Center & Harvard Medical School |
| 1997 Apr 1997 Aug: |
Research fellow in Seoul National University Medical
Research Center |
| 1997 Sep Present: |
Assistant Professor/Associate Professor in Department
of Molecular Cellular Biology, Sungkyunkwan University School
of Medicine |
Research:
Signal for B cell differentiation
B cell receptor, membrane-bound immunoglobulin, is essential for
B cell maturation as well as humoral immune response. Upon antigenic
encounter, signaling processes occur through accessory signaling
chains, Ig-a and Ig-b, and associated kinases. However, the results
of signaling processes are very different depending on the status
of B cell differentiation. Immature B cell undergoes an activation-induced
cell death upon IgM crosslinking. We are currently using WEHI-231
B cells as a model of immature B cell stage cells. We showed that
WEHI-231 cells had some unique signaling properties as compared
to a mature B cell line. We are also performing experiments with
genetically engineered mice which have mutated genes for
B cell signaling such as BTK and JNK.
In contrast, mature B cells differentiate into plasma cells or memory
B cells upon stimulation through surface IgM. We are interested
in the interaction between follicular dendritic cells and mature
B cells. Currently, a gene for a follicular dendritic cell surface
protein is cloned and we are performing studies to see what kind
of functions it has and their molecular mechanisms.
Mechanism of generation of pathogenetic autoantibody
Autoimmune diseases are inflammatory disorders, which are triggered
by the harmful responses of T cells, B cells, or other cells. Our
laboratory is interested in the mechanism of the generation of autoantibodies
in various autoimmune diseases such as rheumatoid arthritis, SLE,
or atopic dermatitis. Autoantibodies could be generated through
a help from specific autoreactive T cells or the provision of a
strong innate immune stimulus. Using an surface plasmon resonance
technique with BiaCore machine, we are performing studies to detect
autoantibodies in patients serum. We are aiming at identifying
specific B cell receptors for those autoantibodies.
Role of CD99 in lymphocyte differentiation
CD99 molecule is a 32-kDa transmembrane glycoprotein, which is highly
expressed on thymocytes, memory lymphocytes, pancreatic islet cells,
and primitive neuroectodermal cells. CD99 has been functionally
implicated in cell migration, apoptosis, cell adhesion, Th1 cell
differentiation, and intracellular transport of transmembrane proteins,
but the basic molecular mechanism of CD99-mediated signal transduction
is not well known. In T cells, CD99 is known as one of the costimulatory
molecules for T cell receptor. Previously, we showed that CD99 engagement
led to ERK activation and homotypic aggregation. We are currently
performing studies to investigate the role of CD99 in lymphocyte
or other immune cell differentiation.
Publications:
- Kim HJ, Chong KH, Lee J-R, Kim J-Y, Chung DH, Hahn M-J, Kim TJ.
Identification of cyclophilin A as a CD99-binding protein by the yeast two-hybrid
screening. Immunol. Lett (2004) 95:155 (2004)
- Kim HJ, Chong KH, Lee J-R, Kim J-Y, Chung DH, Hahn M-J, Kim TJ.
Identification of cyclophilin A as a CD99-binding protein by the yeast two-hybrid
screening. Immunol Lett (2004) on line published Aug 2nd (2004)
- Yoon SS, Kim HJ, Chung DH, Kim TJ. CD99 costimulation up-regulates
T cell receptor-mediated activation of JNK and AP-1. Mol Cells 18(2):
in press (2004)
- Kim J-Y, Lee M-H, Jeong K-I, Na H-Y, Cha H-S, Koh E-M, Kim TJ.
Detection of antibodies against glucose phosphate isomerase in synovial fluid
of rheumatoid arthritis using surface plasmon resonance (BIACORE) Exp
Mol Med 35:310 (2003)
- Yoon SS, Jung KI, Choi Y-L, Choi EY, Lee I-S, Park SH, Kim TJ.
Engagement of CD99 triggers the exocytic transport of ganglioside GM1
and the reorganization of actin cytoskeleton. FEBS Lett 540(1-3):217 (2003)
- Gil MC, Lee M-H, Seo J-I, Choi Y-L, Jung KC, Park SH, Kim
TJ. Characterization and epitope mapping of two monoclonal
antibodies against human CD99. Exp Mol Med 34(6):411 (2002)
- Kim TJ, Cariappa A, Iacomini J, Tang M, Shih S, Bernards A,
Jacks T, Pillai S. Defective proliferative responses in B lymphocytes
and thymocytes that lack neurofibromin. Mol Immunol 38:701-708
(2002)
- Yoon SS, Kim TJ. WEHI-231 cells are defective in the ligand-induced
internalization of B cell antigen receptor. Immune Network 3:196-202
(2001)
- Sohn HW, Shin YK, Lee I-S, Bae YM, Suh YH, Kim MK, Kim TJ,
Jung K-C, Park WS, Park C-S, Chung DH, Ahn K, Kim IS, Ko YH, Bang
YJ, Kim CW, Park SH. CD99 Regulates the Transport of MHC Class
I Molecules from the Golgi Complex to the Cell Surface. J Immunol
166:787-794 (2001)
- Hahn M-J, Yoon SS, Sohn HW, Song HG, Park SH, Kim TJ. Differential
activation of MAP kinase family members triggered by CD99 engagement.
FEBS Letters 470:350-354 (2000)
|